Display Settings:

Format

Send to:

Choose Destination
    Clin Pharmacol Ther. 2011 Oct;90(4):491-3. doi: 10.1038/clpt.2011.191. Epub 2011 Aug 10.

    Smokeless tobacco as a nicotine delivery device: harm or harm reduction?

    Source

    Division of Clinical Pharmacology and Experimental Therapeutics, Medical Service, San Francisco General Hospital Medical Center, San Francisco, California, USA. nbenowitz@medsfgh.ucsf.edu

    Abstract

    Smokeless tobacco (ST) delivers nicotine in doses similar to those received in cigarette smoking but does not expose the user to the toxic combustion gases and particles that are responsible for most tobacco-induced disease. This Opinion piece discusses the controversies pertaining to ST and health, the pros and cons of ST in harm reduction, and progress in treatment for those who would like to quit ST use.

    PMID:
    21934719
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Nature Publishing Group

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk